immunotherapy for targeted therapies - what do we know helena yu, md
Published 5 years ago • 421 plays • Length 21:23Download video MP4
Download video MP3
Similar videos
-
19:05
what we know about immunotherapy treatments for lung cancer
-
1:46
immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
-
11:12
the future of cancer immunotherapy: combination treatments
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
6:00
immunotherapy for patients with driver mutation - lung cancer video library
-
26:02
doctors discuss: immunotherapy in lung cancer
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
9:35
grace targeted therapies lung cancer 2021 - single agent immunotherapy if driver mutation positive?
-
4:09
immunotherapy combinations: is this the future for treating lung cancer?
-
35:07
the current role of immunotherapy in the treatment of patients with cancer
-
4:14
case based panel discussion - egfr and high pdl1 what is the role of immunotherapy in treatment?
-
6:08
chemo /- immunotherapy for mesothelioma-leading developments & current questions in lung cancer
-
10:59
why is immunotherapy more effective in some cancers than others? - part 1
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
3:09
grace targeted therapies lung cancer 2021 - best treatment patient with a designated kras mutation
-
14:26
what is immunotherapy and its mechanisms of action? part 2